Procept Biorobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
Procept Biorobotics獲得美國FDA批准啓動前列腺癌關鍵隨機臨床研究
Procept Biorobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
Procept Biorobotics獲得美國FDA批准啓動前列腺癌關鍵隨機臨床研究
譯文內容由第三人軟體翻譯。